載入...
Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia for a long time. However, over the last few years, novel agents have produced unprecedented outcomes in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia. With the advent of these targe...
Na minha lista:
| 發表在: | Haematologica |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ferrata Storti Foundation
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821614/ https://ncbi.nlm.nih.gov/pubmed/31585959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208603 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|